| |
| |
|
| Insider
Information: |
Mow Jonathan P |
| Relationship: |
Chief Executive Office... |
| City: |
Malvern |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
132,502 |
|
|
Indirect Shares
|
51,199 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
183,701 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Phasebio Pharmaceuticals Inc |
PHAS |
Chief Executive Office... |
2022-05-20 |
132,502 |
2022-05-20 |
51,199 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-05-20 |
4 |
A |
$0.68 |
$7,438 |
D/D |
10,918 |
132,502 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2021-11-03 |
4 |
OE |
$1.24 |
$24,800 |
D/D |
20,000 |
166,850 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2021-08-27 |
4 |
OE |
$1.24 |
$24,800 |
D/D |
20,000 |
146,850 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2021-05-20 |
4 |
A |
$2.80 |
$11,099 |
D/D |
3,964 |
126,850 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2020-11-20 |
4 |
A |
$3.00 |
$10,929 |
D/D |
3,643 |
122,886 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2020-08-21 |
4 |
OE |
$1.24 |
$12,400 |
D/D |
10,000 |
119,243 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-09-06 |
4 |
OE |
$1.24 |
$23,560 |
D/D |
19,000 |
109,243 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-05-20 |
4 |
OE |
$1.24 |
$23,722 |
D/D |
19,131 |
90,243 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-05-17 |
4 |
OE |
$2.27 |
$45,203 |
D/D |
19,913 |
71,112 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-12-13 |
4 |
B |
$3.69 |
$3,690 |
I/I |
1,000 |
51,199 |
2.58 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-12-10 |
4/A |
B |
$3.85 |
$3,080 |
I/I |
800 |
50,199 |
2.58 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-12-10 |
4 |
B |
$3.85 |
$3,080 |
I/I |
800 |
51,699 |
2.58 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-12-07 |
4/A |
B |
$3.89 |
$2,723 |
I/I |
700 |
49,399 |
2.58 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-12-07 |
4 |
B |
$3.88 |
$8,536 |
I/I |
2,200 |
50,899 |
2.58 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-10-22 |
4 |
A |
$0.00 |
$0 |
I/I |
3,505 |
48,699 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
310 |
310 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
